GlassScriptPhysician profile
Mahmood Alam
NPI 1679593875
$2,465.77
in general payments reported to CMS, 2019-2025
23 companies · $111 in 2025
The $111 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $501 · 2020: $336 · 2021: $563 · 2022: $443 · 2023: $222 · 2024: $291 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $559 · Education: $64.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $558.83 |
| Education | $64.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $505.65 | 2020-2024 | Atacand |
| Boston Scientific Corporation | $287.63 | 2019-2023 | Watchman Flx, Watchman Access System |
| Novartis Pharmaceuticals Corporation | $271.37 | 2019-2025 | |
| Abbott Laboratories | $254.72 | 2020-2023 | Xience Skypoint |
| Pfizer INC. | $215.07 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.52 | 2021-2022 | |
| Medtronic, INC. | $137.50 | 2022-2025 | Onyx Frontier |
| Shockwave Medical, INC | $125.00 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Janssen Pharmaceuticals, INC | $87.13 | 2019-2023 | Xarelto |
| Novo Nordisk INC | $79.53 | 2019-2025 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.87 | 2022 | |
| Edwards Lifesciences Corporation | $59.98 | 2020 | |
| Merck Sharp & Dohme LLC | $35.85 | 2021-2022 | |
| Abiomed | $35.68 | 2024 | Impella |
| Bardy Diagnostics, INC. | $25.00 | 2020 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $22.84 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $16.43 | 2021 | |
| Alnylam Pharmaceuticals INC. | $14.63 | 2023 | Onpattro |
| Lilly USA, LLC | $14.16 | 2019 | |
| Baxter Healthcare | $14.11 | 2024 | Hillrom - Cardiac Ambulatory Monitor |
| Amgen INC. | $13.93 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.72 | 2021 | |
| Philips North America LLC | $12.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mahmood Alam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.